Versameb
Manufacturing · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Hochbergerstrasse 60c, Basel, Basel-City...Phone Number
+41 616382360Website
www.versameb.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Versameb
Versameb is a biotechnology company focused on developing the next generation of RNA therapeutics. Their innovative approach aims to address various medical needs through advanced RNA technology. The company targets healthcare providers and researchers interested in cutting-edge therapeutic solutions. Based in Basel, Switzerland, Versameb is committed to transforming the landscape of RNA-based treatments.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Versameb your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Versameb has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Versameb had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Versameb has new funding data
Versameb, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Versameb is spiking on competitors!
Earning: See what the market has to say on Versameb recently announced quarterly report
Product Launch: Get notified when Versameb launches new products
Congratulate Masked Content for being promoted to Masked Content at Versameb
Recommended Actions
Reach out to Masked Content who joined Versameb as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Versameb is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Versameb is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Versameb.
Versameb financials insights
Gather financial insights about Versameb, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Angel/Seed
$12.1M
2020
Angel/Seed
$6.4M
Versameb Tech Stack
A closer look at the technologies used by Versameb
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Executive Move
Board of Directors
Executive Move
Board of Directors
Executive Move
Board of Directors
Versameb News & Media
Versameb Announces Publication in Molecular Therapy - Nucleic Acids Journal Demonstrating the Potential of Engineered IGF-I mRNA as a Regenerative Therapeutic
BASEL, Switzerland, Dec. 12, 2023 /PRNewswire/ -- Versameb AG ("Versameb"), a pre-clinical stage company focused on transforming RNA therapeutics to treat unmet medical needs, today announced the publication of a scientific manuscript in the internationally recognized scientific journal,...Versameb Names Dr. Alexandre LeBeaut as Chair of the Board of Directors
BASEL, Switzerland, Dec. 5, 2023 /PRNewswire/ -- Versameb AG ("Versameb"), a pre-clinical stage company focused on transforming RNA therapeutics to treat unmet medical needs, today announced that its Board of Directors has unanimously appointed of Dr. Alexandre LeBeaut, MD as Chairman of...Touchlight’s enzymatic doggybone DNA used in the manufacture of Versameb’s VMB-100 for first-in-human clinical study
HAMPTON, England--(BUSINESS WIRE)--Touchlight's enzymatic dbDNA used as a critical starting material for Versameb's VMB-100, for first-in-human clinical study to treat chronic SUI.Versameb AG Announces FDA Clearance of IND Application for VMB-100 in the Treatment of Stress Urinary Incontinence
BASEL, Switzerland, Nov. 16, 2023 /PRNewswire/ -- Versameb AG ("Versameb"), a pre-clinical stage company focused on transforming RNA therapeutics to treat unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND)...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Versameb
Sign Up For FreeTo access detailed company insights
Versameb is a biotechnology company focused on developing the next generation of RNA therapeutics. Their innovative approach aims to address various medical needs through advanced RNA technology. The company targets healthcare providers and researchers interested in cutting-edge therapeutic solutions. Based in Basel, Switzerland, Versameb is commit... Read More
